Literature DB >> 12091326

Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential.

Pilar Martín1, Gloria Martínez Del Hoyo, Fabienne Anjuère, Cristina Fernández Arias, Héctor Hernández Vargas, Africa Fernández-L, Verónica Parrillas, Carlos Ardavín.   

Abstract

We describe a new B220+ subpopulation of immaturelike dendritic cells (B220+ DCs) with low levels of expression of major histocompatibility complex (MHC) and costimulatory molecules and markedly reduced T-cell stimulatory potential, located in the thymus, bone marrow, spleen, and lymph nodes. B220+ DCs display ultrastructural characteristics resembling those of human plasmacytoid cells and accordingly produce interferon-alpha after virus stimulation. B220+ DCs acquired a strong antigen-presenting cell capacity on incubation with CpG oligodeoxynucleotides, concomitant with a remarkable up-regulation of MHC and costimulatory molecules and the production of interleukin-12 (IL-12) and IL-10. Importantly, our data suggest that nonstimulated B220+ DCs represent a subset of physiological tolerogenic DCs endowed with the capacity to induce a nonanergic state of T-cell unresponsiveness, involving the differentiation of T regulatory cells capable of suppressing antigen-specific T-cell proliferation. In conclusion, our data support the hypothesis that B220+ DCs represent a lymphoid organ subset of immature DCs with a dual role in the immune system-exerting a tolerogenic function in steady state but differentiating on microbial stimulation into potent antigen-presenting cells with type 1 interferon production capacity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091326     DOI: 10.1182/blood.v100.2.383

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.

Authors:  Arthur M Krieg
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

Review 2.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

3.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

4.  Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

Authors:  Elina I Zuniga; Dorian B McGavern; Jose L Pruneda-Paz; Chao Teng; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

Review 5.  Plasmacytoid dendritic cells: in search of their niche in immune responses.

Authors:  Winfried Barchet; Amanda Blasius; Marina Cella; Marco Colonna
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa.

Authors:  Amale Laouar; Viraga Haridas; Dorothy Vargas; Xia Zhinan; David Chaplin; Rene A W van Lier; N Manjunath
Journal:  Nat Immunol       Date:  2005-06-05       Impact factor: 25.606

Review 7.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

8.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

Review 9.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

10.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.